TNF and diabetes mellitus: Diacerhein is completely metabolized in the human body, resulting in rhein production, which exerts anti-inflammatory properties locally, decreases the expression of pro-inflammatory cytokines such as IL-1β, TNF-α, IFN-γ, and IL-12, thereby interfering with the occurrence of DM (Malaguti et al., 2008).